# Racial disparities in HIV incidence and PrEP non-adherence among gay, bisexual and other Men who have Sex with Men (MSM) and transgender women using oral PrEP in Brazil: Results from the ImPrEP study

**Authors:** Lucilene Araujo Freitas, Carolina Coutinho, Debora Castanheira, Ronaldo Ismerio, Pedro Leite, Iuri C. Leite, Marcelo Cunha, Josias Freitas, Toni Araujo, Laylla Monteiro, Brenda Hoagland, Mayara S.T. Silva, Marcos Benedetti, Cristina Pimenta, Beatriz Grinsztejn, Valdilea G. Veloso, Thiago S. Torres

PMC · DOI: 10.1016/j.bjid.2026.104614 · 2026-01-29

## TL;DR

This study found higher HIV rates and lower PrEP adherence among Black and Pardo men who have sex with men and transgender women in Brazil, highlighting the role of structural racism in health disparities.

## Contribution

The study reveals racial disparities in HIV incidence and PrEP non-adherence in Brazil, emphasizing the impact of structural inequities on health outcomes.

## Key findings

- Black and Pardo participants had higher PrEP non-adherence compared to White participants.
- HIV incidence was higher among Black participants with PrEP non-adherence compared to Pardo and White participants.
- Structural racism and social inequities were identified as key factors affecting health outcomes in marginalized racial groups.

## Abstract

Access to health services may affect PrEP uptake, adherence, and persistance, especially among persons affected by structural inequities. We assessed the HIV incidence and factors associated with PrEP non-adherence among men who have sex with men (MSM) and transgender women in Brazil, focusing on potential racial disparities.

ImPrEP was a prospective, single-arm, open-label, PrEP implementation study that enrolled 9509 MSM and transgender women in Brazil, Mexico and Peru (February 2018 ‒ June 2021). Participants received oral PrEP with tenofovir disoproxil fumarate and emtricitabine at the enrollment visit and quarterly thereafter. This analysis was restricted to data from 14 HIV/STI clinics in 11 cities from Brazil. We calculated the HIV incidence per 100 person-years using the Poisson model according to race. We used adjusted logistic regression models to identify factors associated with PrEP non-adherence (medication possession rate < 0.6) for White and Black/Pardo participants separately. Trial registration: UTN U1111-1217-6021

Of 3928 participants, 1868 (47.6%) self-identified as White, 1410 (35.9%) Pardo, 595 (15.1%) Black, 42 (1.1%) Asian, and 12 (0.3%) Indigenous. PrEP non-adherence was higher among Black (26.2%) and Pardo (24.2%) compared to White (18.7%) participants (p < 0.0001). Among participants with PrEP non-adherence, HIV incidence was higher among Black (2.16 [95% CI: 0.54‒8.63]) than Pardo (1.49 [95% CI: 0.48‒4.62]) and White (1.00 [95% CI 0.25‒4.01]). In multivariable models, participants aged 18‒30 years, self-identifying as transgender women, and reporting lower number of sex partners had increased odds of PrEP non-adherence among White and Black/Pardo participants. Lower education and transactional sex were associated with increased odds of PrEP non-adherence among Black/Pardo, but not among White participants.

Higher HIV incidence and PrEP non-adherence among racially and ethnically marginalized groups, such as Black and Pardo Brazilians, highlights the impact of structural racism on health outcomes. The implementation of public policies to reduce racial and social inequities in HIV prevention must be prioritized in Brazil.

## Linked entities

- **Chemicals:** tenofovir disoproxil fumarate (PubChem CID 5486830), emtricitabine (PubChem CID 60877)

## Full-text entities

- **Diseases:** HIV/STI (MESH:D012749), discrimination (MESH:D010468), AIDS (MESH:D000163), chlamydia (MESH:D002690), ICL (MESH:D018344), Binge drinking (MESH:D063425), Binge (MESH:D002032), syphilis (MESH:D013587), gonorrhea (MESH:D006069), HIV (MESH:D015658), PL (OMIM:614338)
- **Chemicals:** MC (MESH:C061001), substance (MESH:C012600), tenofovir diphosphate (MESH:C583447), cocaine (MESH:D003042), GHB (-), tenofovir disoproxil fumarate (MESH:D000068698), ICL (MESH:C009813), LSD (MESH:D008238)
- **Species:** Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus 1 (no rank) [taxon 11676]
- **Cell lines:** -1217-6021 — Homo sapiens (Human), Transformed cell line (CVCL_1V56)

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12873721/full.md

---
Source: https://tomesphere.com/paper/PMC12873721